International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels

Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri (A.D.W.); Departments of Microbiology and Molecular Genetics (G.A.G.) and Physiology and Biophysics (K.G.C.), University of California, Irvine, Irvine, California; Molecular and Cellular Physiology Department, Stanford University, Stanford, California (R.A.); Department of Medical Pharmacology and Toxicology, University of California, Davis, Davis, California (H.W.); and Department of Applied Physiology, University Ulm, Ulm, Germany (S.G.)

[1]  R. Aldrich,et al.  Erectile dysfunction in mice lacking the large‐conductance calcium‐activated potassium (BK) channel , 2005, The Journal of physiology.

[2]  Tao Xu,et al.  BmP09, a “Long Chain” Scorpion Peptide Blocker of BK Channels* , 2005, Journal of Biological Chemistry.

[3]  I. Grgic,et al.  Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[4]  A. Nomeir,et al.  Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice , 2005, European journal of immunology.

[5]  IvicaGrgic,et al.  Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo , 2005 .

[6]  D. H. Cox The BKCa Channel's Ca2+-binding Sites, Multiple Sites, Multiple Ions , 2005, The Journal of general physiology.

[7]  T. Begenisich,et al.  Physiological Roles of the Intermediate Conductance, Ca2+-activated Potassium Channel Kcnn4* , 2004, Journal of Biological Chemistry.

[8]  P. Christophersen,et al.  Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). , 2004, Biochimica et biophysica acta.

[9]  J. Schuhmacher,et al.  Selective intermediate‐/small‐conductance calcium‐activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma , 2004, The European journal of neuroscience.

[10]  M. Stocker Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.

[11]  M. Mann,et al.  Protein Kinase CK2 Is Coassembled with Small Conductance Ca2+-Activated K+ Channels and Regulates Channel Gating , 2004, Neuron.

[12]  R. Aldrich,et al.  Overactive Bladder and Incontinence in the Absence of the BK Large Conductance Ca2+-activated K+ Channel* , 2004, Journal of Biological Chemistry.

[13]  J F Storm,et al.  Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Lingle,et al.  Ligand-Dependent Activation of Slo Family Channels Is Defined by Interchangeable Cytosolic Domains , 2004, The Journal of Neuroscience.

[15]  R. Stackman,et al.  Small Conductance Ca2+-Activated K+ Channel Knock-Out Mice Reveal the Identity of Calcium-Dependent Afterhyperpolarization Currents , 2004, The Journal of Neuroscience.

[16]  S. Marx,et al.  Assembly of a Ca2+‐dependent BK channel signaling complex by binding to β2 adrenergic receptor , 2004, The EMBO journal.

[17]  Michael Pennington,et al.  K+ channels as targets for specific immunomodulation. , 2004, Trends in pharmacological sciences.

[18]  Rodrigo Andrade,et al.  SKCa Channels Mediate the Medium But Not the Slow Calcium-Activated Afterhyperpolarization in Cortical Neurons , 2004, The Journal of Neuroscience.

[19]  K. Chandy,et al.  Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. , 2004, The Journal of clinical investigation.

[20]  L. Kaczmarek,et al.  Slick (Slo2.1), a Rapidly-Gating Sodium-Activated Potassium Channel Inhibited by ATP , 2003, The Journal of Neuroscience.

[21]  Yi Zhang,et al.  Molecular Identification and Functional Roles of a Ca2+-activated K+ Channel in Human and Mouse Hearts* , 2003, Journal of Biological Chemistry.

[22]  J. Adelman,et al.  Urinary bladder instability induced by selective suppression of the murine small conductance calcium-activated potassium (SK3) channel. , 2003, The Journal of physiology.

[23]  K. Chandy,et al.  Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis , 2003, Circulation.

[24]  J. Stasch,et al.  4-Phenyl-4H-pyrans as IK(Ca) channel blockers. , 2003, Bioorganic & medicinal chemistry letters.

[25]  Mark S Taylor,et al.  Altered Expression of Small‐Conductance Ca2+‐Activated K+ (SK3) Channels Modulates Arterial Tone and Blood Pressure , 2003, Circulation research.

[26]  P. Sah,et al.  Calcium-Activated Potassium Channels: Multiple Contributions to Neuronal Function , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[27]  J. Stocker,et al.  ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. , 2003, Blood.

[28]  L. Kaczmarek,et al.  The Sodium-Activated Potassium Channel Is Encoded by a Member of the Slo Gene Family , 2003, Neuron.

[29]  A. Pries,et al.  Selective blockade of endothelial Ca2+‐activated small‐ and intermediate‐conductance K+‐channels suppresses EDHF‐mediated vasodilation , 2003, British journal of pharmacology.

[30]  K. Magleby Gating Mechanism of BK (Slo1) Channels , 2003, The Journal of general physiology.

[31]  L. Kaczmarek,et al.  Localization of the Slack potassium channel in the rat central nervous system , 2002, The Journal of comparative neurology.

[32]  J. Joseph,et al.  Tamapin, a Venom Peptide from the Indian Red Scorpion (Mesobuthus tamulus) That Targets Small Conductance Ca2+-activated K+ Channels and Afterhyperpolarization Currents in Central Neurons* , 2002, The Journal of Biological Chemistry.

[33]  D. Trezise,et al.  Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  C. Lingle Setting the Stage for Molecular Dissection of the Regulatory Components of BK Channels , 2002, The Journal of general physiology.

[35]  J. Qin,et al.  Mechanism of magnesium activation of calcium-activated potassium channels , 2002, Nature.

[36]  C. Lingle,et al.  Multiple regulatory sites in large-conductance calcium-activated potassium channels , 2002, Nature.

[37]  P. Vanhoutte,et al.  Characterization of an apamin‐sensitive small‐conductance Ca2+‐activated K+ channel in porcine coronary artery endothelium: relevance to EDHF , 2002, British journal of pharmacology.

[38]  I. Levitan,et al.  Modulation of calcium-activated potassium channels , 2002, Journal of Comparative Physiology A.

[39]  K. Chandy,et al.  Modulation of Mouse Paneth Cell α-Defensin Secretion by mIKCa1, a Ca2+-activated, Intermediate Conductance Potassium Channel* , 2002, The Journal of Biological Chemistry.

[40]  K. Chandy,et al.  Design and Characterization of a Highly Selective Peptide Inhibitor of the Small Conductance Calcium-activated K+Channel, SkCa2* , 2001, The Journal of Biological Chemistry.

[41]  Jingyi Shi,et al.  Intracellular Mg2+ Enhances the Function of Bk-Type Ca2+-Activated K+ Channels , 2001, The Journal of general physiology.

[42]  L. Kaczmarek,et al.  Calmodulin regulates assembly and trafficking of SK4/IK1 Ca2+-activated K+ channels. , 2001, The Journal of biological chemistry.

[43]  D. Geschwind,et al.  Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia. , 2001, Archives of neurology.

[44]  J. Adelman,et al.  Small‐conductance calcium‐activated potassium currents in mouse hyperexcitable denervated skeletal muscle , 2001, The Journal of physiology.

[45]  D. Jenkinson,et al.  SK3 is an important component of K+ channels mediating the afterhyperpolarization in cultured rat SCG neurones , 2001, The Journal of physiology.

[46]  S Athmani,et al.  Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes. , 2001, Journal of medicinal chemistry.

[47]  J. Gargus,et al.  Genomic organization and promoter analysis of human KCNN3 gene , 2001, Journal of Human Genetics.

[48]  Mark J. Miller,et al.  Nuclear Localization and Dominant-negative Suppression by a Mutant SKCa3 N-terminal Channel Fragment Identified in a Patient with Schizophrenia* , 2001, The Journal of Biological Chemistry.

[49]  Kamilla Angelo,et al.  Pharmacological modulation of SK3 channels , 2001, Neuropharmacology.

[50]  Jochen Roeper,et al.  Differential Expression of the Small-Conductance, Calcium-Activated Potassium Channel SK3 Is Critical for Pacemaker Control in Dopaminergic Midbrain Neurons , 2001, The Journal of Neuroscience.

[51]  M. Gopalakrishnan,et al.  Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. , 2001, Journal of medicinal chemistry.

[52]  L. Jones,et al.  Mutation screening of the KCNN3 gene reveals a rare frameshift mutation , 2001, Molecular Psychiatry.

[53]  J. Adelman,et al.  Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin , 2001, Nature.

[54]  A. Moore,et al.  Cloning and functional expression of a liver isoform of the small conductance Ca2+-activated K+ channel SK3. , 2001, American journal of physiology. Cell physiology.

[55]  Astrid A. Ortiz,et al.  Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels , 2001, Nature Medicine.

[56]  B. Fakler,et al.  Control of Electrical Activity in Central Neurons by Modulating the Gating of Small Conductance Ca2+-activated K+ Channels* , 2001, The Journal of Biological Chemistry.

[57]  M. T. Roberts,et al.  Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds. , 2001, The Journal of pharmacology and experimental therapeutics.

[58]  A. K. Singh,et al.  Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. , 2001, The Journal of pharmacology and experimental therapeutics.

[59]  S. Sakoda,et al.  The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy , 2000, Neuroscience Letters.

[60]  Mark J. Miller,et al.  Up-regulation of the IKCa1 Potassium Channel during T-cell Activation , 2000, The Journal of Biological Chemistry.

[61]  R. Köhler,et al.  Expression and Function of Endothelial Ca2+-Activated K+ Channels in Human Mesenteric Artery: A Single-Cell Reverse Transcriptase–Polymerase Chain Reaction and Electrophysiological Study In Situ , 2000, Circulation research.

[62]  D. Strøbæk,et al.  Activation of the human, intermediate-conductance, Ca2+-activated K+ channel by methylxanthines , 2000, Pflügers Archiv.

[63]  L. Salkoff,et al.  SLO-2, a K+ channel with an unusual Cl− dependence , 2000, Nature Neuroscience.

[64]  M. T. Roberts,et al.  Block of rat brain recombinant SK channels by tricyclic antidepressants and related compounds. , 2000, European journal of pharmacology.

[65]  K. Chandy,et al.  Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  P. Distefano,et al.  A Novel Nervous System β Subunit that Downregulates Human Large Conductance Calcium-Dependent Potassium Channels , 2000, The Journal of Neuroscience.

[67]  S. F. Konieczny,et al.  Ras/MEK/ERK Up-regulation of the Fibroblast KCaChannel FIK Is a Common Mechanism for Basic Fibroblast Growth Factor and Transforming Growth Factor-β Suppression of Myogenesis* , 2000, The Journal of Biological Chemistry.

[68]  P. Pedarzani,et al.  Differential Distribution of Three Ca2+-Activated K+ Channel Subunits, SK1, SK2, and SK3, in the Adult Rat Central Nervous System , 2000, Molecular and Cellular Neuroscience.

[69]  S. Grissmer,et al.  SK2 encodes the apamin‐sensitive Ca2+‐activated K+ channels in the human leukemic T cell line, Jurkat , 2000, FEBS letters.

[70]  D. Strøbæk,et al.  Pharmacological characterization of small‐conductance Ca2+‐activated K+ channels stably expressed in HEK 293 cells , 2000, British journal of pharmacology.

[71]  M. Shah,et al.  The pharmacology of hSK1 Ca2+‐activated K+ channels expressed in mammalian cell lines , 2000, British journal of pharmacology.

[72]  K. Chandy,et al.  Structure-guided Transformation of Charybdotoxin Yields an Analog That Selectively Targets Ca2+-activated over Voltage-gated K+ Channels* , 2000, The Journal of Biological Chemistry.

[73]  D. Valle,et al.  Online Mendelian Inheritance In Man (OMIM) , 2000, Human mutation.

[74]  S. Heinemann,et al.  Identification of Ether à Go-Go and Calcium-Activated Potassium Channels in Human Melanoma Cells , 1999, The Journal of Membrane Biology.

[75]  D. Strøbæk,et al.  Activation of the human intermediate-conductance Ca(2+)-activated K(+) channel by 1-ethyl-2-benzimidazolinone is strongly Ca(2+)-dependent. , 1999, Biochimica et biophysica acta.

[76]  A. Bruening-Wright,et al.  Bicuculline block of small-conductance calcium-activated potassium channels , 1999, Pflügers Archiv.

[77]  C. Lingle,et al.  Molecular Basis for the Inactivation of Ca2+- and Voltage-Dependent BK Channels in Adrenal Chromaffin Cells and Rat Insulinoma Tumor Cells , 1999, The Journal of Neuroscience.

[78]  N. Craddock,et al.  CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia , 1999, Biological Psychiatry.

[79]  A. Janowsky,et al.  Skeletal muscle and small‐conductance calcium‐activated potassium channels , 1999, Muscle & nerve.

[80]  L. Kaczmarek,et al.  hSK4/hIK1, a Calmodulin-binding KCa Channel in Human T Lymphocytes , 1999, The Journal of Biological Chemistry.

[81]  L. Salkoff,et al.  Transplantable sites confer calcium sensitivity to BK channels , 1999, Nature Neuroscience.

[82]  R. Weizman,et al.  hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21 , 1999, Molecular Psychiatry.

[83]  J. Adelman,et al.  Small‐Conductance Calcium‐Activated Potassium Channels , 1999, Annals of the New York Academy of Sciences.

[84]  K. Chandy,et al.  Calmodulin Mediates Calcium-dependent Activation of the Intermediate Conductance KCa Channel,IKCa1 * , 1999, The Journal of Biological Chemistry.

[85]  L. Kaczmarek,et al.  Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits , 1998, Nature Neuroscience.

[86]  T. Ishii,et al.  Mechanism of calcium gating in small-conductance calcium-activated potassium channels , 1998, Nature.

[87]  K. Chandy,et al.  Human calcium-activated potassium channel gene KCNN4 maps to chromosome 19q13.2 in the region deleted in diamond-blackfan anemia. , 1998, Genomics.

[88]  Neil V Marrion,et al.  Calcium-activated potassium channels , 1998, Current Opinion in Neurobiology.

[89]  Jiuyong Xie,et al.  Control of alternative splicing of potassium channels by stress hormones. , 1998, Science.

[90]  N. Marrion,et al.  Gating of Recombinant Small-Conductance Ca-activated K+ Channels by Calcium , 1998, The Journal of general physiology.

[91]  L. Salkoff,et al.  Slo3, a Novel pH-sensitive K+ Channel from Mammalian Spermatocytes* , 1998, The Journal of Biological Chemistry.

[92]  E. Christian,et al.  A Novel Gene, hKCa4, Encodes the Calcium-activated Potassium Channel in Human T Lymphocytes* , 1997, The Journal of Biological Chemistry.

[93]  S. Alper,et al.  The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. , 1997, The Journal of clinical investigation.

[94]  L. Toro,et al.  Large conductance voltage- and calcium-dependent K+ channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[95]  T. Ishii,et al.  A human intermediate conductance calcium-activated potassium channel. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[96]  L. Kaczmarek,et al.  hSK4, a member of a novel subfamily of calcium-activated potassium channels. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[97]  T. Ishii,et al.  Determinants of Apamin and d-Tubocurarine Block in SK Potassium Channels* , 1997, The Journal of Biological Chemistry.

[98]  L. Salkoff,et al.  A novel calcium-sensing domain in the BK channel. , 1997, Biophysical journal.

[99]  O. McManus,et al.  Paxilline Inhibition of the Alpha-subunit of the High-conductance Calcium-activated Potassium Channel , 1996, Neuropharmacology.

[100]  D. Strøbæk,et al.  Modulation of the Ca2+-dependent K+ Channel, hslo, by the Substituted Diphenylurea NS 1608, Paxilline and Internal Ca2+ , 1996, Neuropharmacology.

[101]  N. Marrion,et al.  Small-Conductance, Calcium-Activated Potassium Channels from Mammalian Brain , 1996, Science.

[102]  O. McManus,et al.  High-conductance calcium-activated potassium channels; Structure, pharmacology, and function , 1996, Journal of bioenergetics and biomembranes.

[103]  O. Platt,et al.  Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. , 1996, The Journal of clinical investigation.

[104]  J. Tseng-Crank,et al.  Cloning, expression, and distribution of functionally distinct Ca2+-activated K+ channel isoforms from human brain , 1994, Neuron.

[105]  L. Salkoff,et al.  Calcium sensitivity of BK-type KCa channels determined by a separable domain , 1994, Neuron.

[106]  R. North,et al.  Functional differences among alternatively spliced variants of Slowpoke, a Drosophila calcium-activated potassium channel. , 1994, The Journal of biological chemistry.

[107]  L. Pallanck,et al.  Cloning and characterization of human and mouse homologs of the Drosophila calcium-activated potassium channel gene, slowpoke. , 1994, Human molecular genetics.

[108]  M. Garcia-Calvo,et al.  Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. , 1994, The Journal of biological chemistry.

[109]  O. McManus,et al.  Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. , 1994, The Journal of biological chemistry.

[110]  S. Grissmer,et al.  Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology , 1993, The Journal of general physiology.

[111]  L. Salkoff,et al.  mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. , 1993, Science.

[112]  O. McManus,et al.  An activator of calcium-dependent potassium channels isolated from a medicinal herb. , 1993, Biochemistry.

[113]  N. Atkinson,et al.  A component of calcium-activated potassium channels encoded by the Drosophila slo locus. , 1991, Science.

[114]  H. Irisawa,et al.  Intracellular Na+ activates a K+ channel in mammalian cardiac cells , 1984, Nature.

[115]  G. Gardos,et al.  The function of calcium in the potassium permeability of human erythrocytes. , 1958, Biochimica et biophysica acta.

[116]  L. Rüttiger,et al.  Deletion of the Ca2+-activated potassium (BK) alpha-subunit but not the BKbeta1-subunit leads to progressive hearing loss. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Abraham Weizman,et al.  Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study , 2002, Molecular Psychiatry.

[118]  D. H. Cox,et al.  Elimination of the BK Ca Channel’s High-Affinity Ca 2 (cid:2) Sensitivity , 2002 .

[119]  L. Possani,et al.  Slotoxin, alphaKTx1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between alpha and alpha+beta (beta1 or beta4) complexes. , 2001, FEBS letters.

[120]  Jingyi Shi,et al.  Intracellular Mg 2 Enhances the Function of BK-type Ca 2-activated K Channels , 2001 .

[121]  Mark J. Miller,et al.  Selective blockers and manipulated channel expression levels , 2001 .

[122]  K. Chandy,et al.  Design and Characterization of a Highly Selective Peptide Inhibitor of the Small Conductance Calcium-activated K Channel , SkCa 2 * , 2001 .

[123]  K. Magleby,et al.  Gating and conductance properties of BK channels are modulated by the S9-S10 tail domain of the alpha subunit. A study of mSlo1 and mSlo3 wild-type and chimeric channels. , 2001, The Journal of general physiology.

[124]  L. Toro,et al.  Human and rodent MaxiK channel beta-subunit genes: cloning and characterization. , 1999, Genomics.

[125]  R. Latorre,et al.  Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. , 1999, Science.

[126]  P. Christophersen,et al.  Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[127]  G A Gutman,et al.  Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? , 1998, Molecular Psychiatry.

[128]  J. Ding,et al.  Calcium-activated potassium channels in adrenal chromaffin cells. , 1996, Ion channels.

[129]  M. Lazdunski,et al.  Apamin: a specific toxin to study a class of Ca2+-dependent K+ channels. , 1984, Journal de physiologie.